Risks Related to Healthcare Regulation, Sensitive Information Leakage and Service Quality
First written in FY2019. 1 of 3 entries say "Restated". Latest entry: FY2026.
DeNA moved to the "Worse" side of this theme in 2026.
0 other companies' latest entry also says "Reframed".
- FY2026ReframedAnnual report
「In this business, we are developing our services and conducting research and development so as not to violate the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, the Medical Practitioners’ Act, the Act on the Protection of Personal Information or other domestic and overseas laws and regulations. However, if certification systems become applicable to this business area or the equipment handled, or if amendments to relevant laws and regulations or laws and regulations governing the handling of healthcare data impose restrictions on the business or result in additional costs, our group’s financial results and other matters may be affected.」
The risks of the healthcare and medical businesses were specified as including the Pharmaceuticals and Medical Devices Act, the Medical Practitioners’ Act, certification systems for equipment, domestic and overseas data regulations, and additional costs resulting from regulatory amendments. - FY2023RestatedAnnual report
「The business handles large volumes of highly sensitive information, including individuals’ health-screening and genetic information, as well as information obtained through anonymization, statistical processing and other methods. As the business becomes more diversified, the volume and variety of information handled are also expected to increase. In the event of an information leak or improper handling, our group may face substantial damages claims or administrative sanctions.」
Risks relating to regulation, leakage of sensitive information and service quality in the healthcare and medical businesses remain following the expansion of the businesses. - FY2019First statedAnnual report
「The business handles large volumes of highly sensitive information, including individuals’ health-screening and genetic information. As the business becomes more diversified, the volume and variety of information handled are also expected to increase. In the event of an information leak or improper handling, our group may face substantial damages claims or administrative sanctions.」
The company expressly identifies healthcare-related laws and regulations, leakage of health-screening and genetic information, and damages claims or administrative sanctions resulting from inaccurate or defective tests and services as risks.